Dexamethasone, high-dose cytarabine, and cisplatin in combination with rituximab as salvage treatment for patients with relapsed or refractory aggressive non-Hodgkin's lymphoma.
Mey UJ, Orlopp KS, Flieger D, Strehl JW, Ho AD, Hensel M, Bopp C, Gorschlüter M, Wilhelm M, Birkmann J, Kaiser U, Neubauer A, Florschütz A, Rabe C, Hahn C, Glasmacher AG, Schmidt-Wolf IG.
Mey UJ, et al. Among authors: glasmacher ag.
Cancer Invest. 2006 Oct;24(6):593-600. doi: 10.1080/07357900600814490.
Cancer Invest. 2006.
PMID: 16982464
Clinical Trial.